Home Commercial Calisseo’s Chinese factory on track to deliver commercial quantities of FeedKind this year

Calisseo’s Chinese factory on track to deliver commercial quantities of FeedKind this year

0

Calysseo, a joint venture between animal nutrition supplier Adisseo and Calysta, will produce 20,000 tonnes of FeedKind protein per year from its new plant in Chongqing, China.

The microbial protein is produced via a natural fermentation that uses no arable land, animal or vegetable matter, and uses very little water in its production. Initially, production will be available for use in China, the largest aquaculture market in the world.

While operating under Covid-19 restrictions, the Calisseo team has maintained the historic installation schedule, which means FeedKind is expected to be delivered to the first customers this year.

“This is an important step as we move towards more sustainable forms of food manufacturing. Calysseo and FeedKind offer a world first, a new sustainable, nutritious and non-GMO protein that offers significant health benefits over other food ingredients, such as better gut health and improved immune response,” said Jean- Marc Dublanc, CEO of Adisseo, in a press release.

“We have a long-standing commitment to improving the safety and sustainability of the food ingredients market and Calisseo fulfills an important part of this commitment. We will provide Chinese customers with a reliable, domestically available protein supply that meets their specific needs; produced in China for China,” he added.

Dr. Alan Shaw, Co-Founder, CEO and President of Calysta, said: “Cellular agriculture, where proteins are grown in a controlled environment, is essential to helping the world meet its future food needs. Today will go down in history as an extremely important moment in the development and supply of new, sustainable sources of protein to meet growing global demand.

“For Calysta, today is the result of years of work to develop a protein without limits, which meets our growing demand for protein while protecting biodiversity. It also marks the start of a new phase in Calysta’s history as we work to produce additional protein ingredients for food and feed applications.

Pierre Casamatta, co-CEO of Calysseo, added: “The start of the commissioning and start-up activities of our first installation on schedule is a moment of which I am extremely proud. We are doing something that has never been done before on a large scale – reaching this milestone in such a short time during the extremely difficult implications of Covid-19 is incredibly rewarding and a testament to the skill and commitment of Calisseo team, and that of our JV partners.

FeedKind has been validated over several years after extensive trials on several popular aquaculture species including sea bass, sea bream and salmon. Thailand’s Kasetsart University, Thailand, recently discovered distinct benefits for shrimp, claiming that FeedKind promotes strong and healthy growth, while helping to activate the shrimp’s immune response to Vibrio, the causative agent of Shrimp Syndrome. early mortality (EMS).